RESUMO
BACKGROUND AND PURPOSE: To test the hypothesis that myoclonic seizures can evolve to tonic seizures, we documented the electroclinical features of this under-recognized seizure type. METHODS: We observed a distinct seizure pattern starting with myoclonus without returning to an interictal state, which subsequently evolved into generalized tonic seizures. The detailed symptomatic and electroencephalographic characteristics of this seizure were extracted, and the clinical manifestations, drug curative responses in patients with this seizure were reviewed and analyzed. RESULTS: The onset of all seizures was characterized by a preceding period of myoclonus and bursts of generalized spike or poly-spike slow wave discharges with high amplitude. This was closely followed by the occurrence of tonic seizures, which were distinguished by bursts of generalized fast activity at 10 Hz or higher frequency. This under-recognized seizure type has been designated as myoclonic-to-tonic (MT) seizure. The number of patients identified with MT seizures in this study was 34. The prevalence rate of MT seizures was found to be higher in males. While MT seizures typically included a tonic component, it should be noted that some patients experiencing this seizure type never presented with isolated tonic seizures. Generalized Epilepsy not further defined (GE) accounted for approximately one-third of the diagnosed cases, followed by Lennox-Gastaut syndrome and Epilepsy with Myoclonic-Atonic seizures. In comparison to other types of epilepsy, GE with MT seizures demonstrated a more favorable prognosis. CONCLUSIONS: The classification of myoclonic-to-tonic seizure represents a novel approach in comprehending the ictogenesis of generalized seizures and can provide valuable assistance to clinicians in epilepsy diagnosis.
Assuntos
Eletroencefalografia , Epilepsias Mioclônicas , Convulsões , Humanos , Masculino , Feminino , Eletroencefalografia/métodos , Adulto , Adolescente , Convulsões/fisiopatologia , Convulsões/diagnóstico , Criança , Adulto Jovem , Epilepsias Mioclônicas/fisiopatologia , Epilepsias Mioclônicas/diagnóstico , Epilepsia Generalizada/fisiopatologia , Epilepsia Generalizada/diagnóstico , Pré-Escolar , Pessoa de Meia-Idade , Mioclonia/fisiopatologia , Mioclonia/diagnóstico , LactenteRESUMO
PURPOSE OF REVIEW: Myoclonus, a common hyperkinetic movement disorder, can be disabling for patients. It is important to identify and classify myoclonus correctly to ensure appropriate workup and treatment. While the clinical history, examination, and process of classifying myoclonus remain largely unchanged, new causes and triggers for myoclonus are being elucidated, and new genetic causes have been found. Treatment can be challenging, though preliminary data about new options has been promising. RECENT FINDINGS: In this article, we will briefly outline the process of classifying and treating myoclonus. We will then discuss three specific scenarios where myoclonus has been identified: myoclonus associated with SARS-CoV-2 infections, spinal myoclonus following surgery or anesthesia of the spine, and auricular myoclonus. We will also discuss new genetic findings associated with myoclonus-dystonia, and promising results regarding the use of perampanel in treating myoclonus. SUMMARY: The process of describing unique scenarios associated with myoclonus has helped us build our understanding of the causes, genetic background, expected prognosis, and effective treatment of specific types of myoclonus. We hope that further studies on this topic will help tailor treatment.
Assuntos
COVID-19 , Mioclonia , Humanos , Mioclonia/diagnóstico , Mioclonia/terapia , Mioclonia/genética , Mioclonia/fisiopatologia , COVID-19/complicaçõesRESUMO
BACKGROUND: Subacute sclerosing panencephalitis (SSPE) is a complication of measles, occurring after a latency of 4-10 years. It continues to occur in developing countries although resurgence is being reported from developed countries. Characteristic features include progressive neuropsychiatric issues, myoclonus, seizures, movement disorders and visual impairment. Electroencephalography (EEG) typically shows periodic generalized discharges, and elevated CSF anti-measles antibodies are diagnostic. Movement disorders are being increasingly recognized as part of the clinical spectrum, and range from hyperkinetic (chorea, dystonia, tremor, tics) to hypokinetic (parkinsonism) disorders and ataxia. OBJECTIVES: This article aims to comprehensively review the spectrum of movement disorders associated with SSPE. METHODS: A literature search was conducted in PubMed and EMBASE databases in December 2023 and articles were identified for review. RESULTS: Movement disorders reported in SSPE included hyperkinetic (chorea, dystonia, tremor and tics), hypokinetic (parkinsonism), ataxia and extraocular movement disorders. Myoclonus, a core clinical feature, was the most frequent "abnormal movement." Movement disorders were observed in all clinical stages, and could also be a presenting feature, even sans myoclonus. Hyperkinetic movement disorders were more common than hypokinetic movement disorders. An evolution of movement disorders was observed, with ataxia, chorea and dystonia occurring earlier, and parkinsonism later in the disease. Neuroradiological correlates of movement disorders remained unclear. CONCLUSION: A wide spectrum of movement disorders was observed throughout the clinical stages of SSPE. Most data were derived from case reports and small case series. Multicentric longitudinal studies are required to better delineate the spectrum and evolution of movement disorders in SSPE.
Assuntos
Transtornos dos Movimentos , Panencefalite Esclerosante Subaguda , Humanos , Coreia/etiologia , Coreia/fisiopatologia , Coreia/diagnóstico , Distonia/etiologia , Distonia/fisiopatologia , Eletroencefalografia , Transtornos dos Movimentos/etiologia , Transtornos dos Movimentos/fisiopatologia , Transtornos dos Movimentos/diagnóstico , Mioclonia/etiologia , Mioclonia/fisiopatologia , Panencefalite Esclerosante Subaguda/complicações , Panencefalite Esclerosante Subaguda/diagnóstico , Panencefalite Esclerosante Subaguda/fisiopatologia , Tremor/etiologiaAssuntos
Mioclonia , Humanos , Mioclonia/fisiopatologia , Mioclonia/genética , Masculino , Feminino , Estimulação Luminosa/métodos , Doenças Genéticas Ligadas ao Cromossomo X/genética , Doenças Genéticas Ligadas ao Cromossomo X/fisiopatologia , Degeneração Retiniana/fisiopatologia , Degeneração Retiniana/genética , Reflexo/fisiologia , Proteínas Serina-Treonina Quinases/genética , Síndromes Epilépticas , Espasmos InfantisRESUMO
STUDY OBJECTIVES: Excessive fragmentary myoclonus (EFM) is a frequent finding in patients undergoing video-polysomnography (VPSG). We aimed to evaluate the potential effect of sleep-related breathing disorder's treatment with positive airway pressure (PAP) therapy on EFM. METHODS: One hundred consecutive patients with EFM and sleep-related breathing disorder subsequently treated with PAP at the sleep lab of the Medical University of Innsbruck, Department of Neurology, Austria, were included. Each patient underwent two nights of VPSG: the first night without and the second night with PAP therapy. Fragmentary myoclonus was automatically scored with validated software, and fragmentary myoclonus index (FMI) and minutes of non-rapid eye movement (NREM) sleep with EFM (minNREM+EFM) were calculated. RESULTS: Under PAP therapy there was a significant decrease in the minNREM+EFM - 60.5 (9.5-161.8) at baseline vs. 37.5 (6.3-168.8) minutes under PAP, p = 0.025. No significant differences were observed for FMI between the two nights. Sleep variables, sleep diagnoses, comorbidities, and medication did not influence FMI or the minNREM+EFM. CONCLUSIONS: The initiation of PAP treatment led to a significant reduction of minNREM+EFM, but not of FMI. The results suggest that PAP therapy might influence the distribution of FM potentials.
Assuntos
Pressão Positiva Contínua nas Vias Aéreas , Polissonografia , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Pressão Positiva Contínua nas Vias Aéreas/métodos , Síndromes da Apneia do Sono/terapia , Adulto , Síndrome da Mioclonia Noturna/terapia , Idoso , Mioclonia/terapia , Mioclonia/fisiopatologiaRESUMO
INTRODUCTION: Negative myoclonus (NM) is an involuntary movement caused by a sudden interruption of muscular activity, resulting in gait problems and falls. OBJECTIVE: To establish frequency, clinical impact, and neurophysiology of NM in progressive myoclonus ataxia (PMA) patients. METHODS: Clinical, neurophysiological, and genetic data of 14 PMA individuals from University Medical Centre Groningen (UMCG) Expertise Center Movement Disorder Groningen were retrospectively collected. Neurophysiological examination included video-electromyography-accelerometry assessment in all patients and electroencephalography (EEG) examination in 13 individuals. Jerk-locked (or silent period-locked) back-averaging and cortico-muscular coherence (CMC) analysis aided the classification of myoclonus. RESULTS: NM was present in 6 (NM+) and absent in 8 (NM-) PMA patients. NM+ individuals have more frequent falls (100% vs. 37.5%) and higher scores on the Gross Motor Function Classification System (GMFCS) (4.3 ±0.74 vs. 2.5 ±1.2) than NM- individuals. Genetic background of NM+ included GOSR2 and SEMA6B, while that of NM- included ATM, KCNC3, NUS1, STPBN2, and GOSR2. NM was frequently preceded by positive myoclonus (PM) and silent-period length was between 88 and 194 ms. EEG epileptiform discharges were associated with NM in 2 cases. PM was classified as cortical in 5 NM+ and 2 NM- through EEG inspection, jerk-locked back-averaging, or CMC analysis. DISCUSSION: Neurophysiological examination is crucial for detecting NM that could be missed on clinical examination due to a preceding PM. Evidence points to a cortical origin of NM, an association with more severe motor phenotype, and suggests the presence of genetic disorders causing either a PMA or progressive myoclonus epilepsy, rather than pure PMA phenotype. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Assuntos
Eletroencefalografia , Eletromiografia , Mioclonia , Proteínas Qb-SNARE , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Eletroencefalografia/métodos , Adulto , Mioclonia/fisiopatologia , Mioclonia/diagnóstico , Estudos Retrospectivos , Idoso , Ataxia/fisiopatologiaRESUMO
Epilepsy with eyelid myoclonia (EM) or Jeavons syndrome (JS) is an epileptic syndrome related to the spectrum of genetic generalized epilepsies (GGE). We report two untreated children on which EEGs were performed several hours after a generalized tonic-clonic seizure (GTCS). These showed a unilateral, nearly continuous posterior slowing. This slow-wave activity was associated with contralateral epileptiform activity in one case, while in the second case, it was associated with an ipsilateral activity. However, in the latter child, a few months later an independent focus on the contralateral side was observed. A diagnosis of focal occipital lobe epilepsy was proposed in both cases, and one child underwent a left occipital lobectomy at 3.5 years of age. Despite surgery, absences with EM persisted in this child, and a marked photosensitivity to photic stimulation was observed two years later. The focal slow wave activity of one occipital lobe several hours after a GTCS in these two subjects was in favor of a focal onset preceding the generalization. The EEG evidence for independent left and right posterior focus in these two cases, the persistence of EM, and the development of a marked photosensitivity to photic stimulation in the child who underwent an occipital lobectomy, allow us to suggest that JS is associated with a network of bi-occipital hyperexcitability that rapidly engages bilaterally to produce generalized seizures.
Assuntos
Eletroencefalografia , Epilepsias Parciais , Epilepsia Generalizada , Humanos , Epilepsias Parciais/fisiopatologia , Epilepsias Parciais/diagnóstico , Epilepsias Parciais/complicações , Masculino , Pré-Escolar , Epilepsia Generalizada/fisiopatologia , Epilepsia Generalizada/diagnóstico , Epilepsia Generalizada/complicações , Feminino , Criança , Mioclonia/fisiopatologia , Mioclonia/diagnóstico , Pálpebras/fisiopatologiaAssuntos
Doença de Alexander/fisiopatologia , Mioclonia/fisiopatologia , Prega Vocal/fisiopatologia , Doença de Alexander/complicações , Feminino , Transtornos Neurológicos da Marcha , Proteína Glial Fibrilar Ácida/genética , Humanos , Hipotensão Ortostática , Laringoscopia , Pessoa de Meia-Idade , Mioclonia/etiologiaRESUMO
OBJECTIVE: To develop and test wearable monitoring of surface electromyography and motion for detection and quantification of positive and negative myoclonus in patients with progressive myoclonic epilepsy type 1 (EPM1). METHODS: Surface electromyography and three-dimensional acceleration were measured from 23 EPM1 patients from the biceps brachii (BB) of the dominant and the extensor digitorum communis (EDC) of the non-dominant arm for 48 hours. The patients self-reported the degree of myoclonus in a diary once an hour. Severity of myoclonus with action was evaluated by using video-recorded Unified Myoclonus Rating Scale (UMRS). Correlations of monitored parameters were quantified with the UMRS scores and the self-reported degrees of myoclonus. RESULTS: The monitoring-based myoclonus index correlated significantly (p < 0.001) with the UMRS scores (ρ = 0.883 for BB and ρ = 0.823 for EDC) and with the self-reported myoclonus degrees (ρ = 0.483 for BB and ρ = 0.443 for EDC). Ten patients were assessed as probably having negative myoclonus in UMRS, while our algorithm detected that in twelve patients. CONCLUSIONS: Wearable monitoring was able to detect both positive and negative myoclonus in EPM1 patients. SIGNIFICANCE: Our method is suitable for quantifying objective, real-life treatment effects at home and progression of myoclonus.
Assuntos
Acelerometria/métodos , Eletromiografia/métodos , Síndrome de Unverricht-Lundborg/diagnóstico , Síndrome de Unverricht-Lundborg/fisiopatologia , Dispositivos Eletrônicos Vestíveis , Acelerometria/instrumentação , Adolescente , Adulto , Eletromiografia/instrumentação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mioclonia/diagnóstico , Mioclonia/fisiopatologia , Adulto JovemRESUMO
INTRODUCTION: Chronic post-hypoxic myoclonus is a condition in which the predominant clinical picture is myoclonus following hypoxic brain damage, usually due to cardiorespiratory arrest. It is a condition that is usually treated with antiepileptic drugs, in most cases with a modest clinical response. CASE REPORT: We report the case of a patient who started with jerking movements, compatible with myoclonus in the four limbs and the face the day after recovering from a cardiorespiratory arrest. An electroencephalogram was performed during which the myoclonias were recorded with no electrical correlates. During admission, and in successive visits after discharge, different antiepileptic treatments were tried for the myoclonias, which were refractory and affected the patient's quality of life. Two years after onset, treatment with perampanel up to a dose of 4 mg was initiated and the patient reported a significant clinical improvement, as evidenced in the visits. CONCLUSIONS: Perampanel may be an effective alternative for the treatment of myoclonias in patients with chronic post-hypoxic myoclonus.
TITLE: Respuesta a perampanel en un paciente con mioclono posthipóxico crónico.Introducción. El mioclono posthipóxico crónico es un cuadro cuya clínica predominante son las mioclonías que acontecen tras un daño cerebral hipóxico, generalmente por parada cardiorrespiratoria. Es una entidad que se trata generalmente con fármacos antiepilépticos, con una modesta respuesta clínica en la mayoría de los casos. Caso clínico. Paciente que comienza con movimientos de sacudidas, compatibles con mioclonías de las cuatro extremidades y faciales al día siguiente de una parada cardiorrespiratoria recuperada. Se realizó un electroencefalograma durante el cual se registraron las mioclonías sin presentar correlato eléctrico. Durante el ingreso, y en sucesivas visitas tras el alta, se probaron diferentes tratamientos antiepilépticos para las mioclonías, que fueron refractarias y comportaron una afectación de la calidad de vida del paciente. Tras dos años de evolución, se inició tratamiento con perampanel hasta una dosis de 4 mg y el paciente refirió una mejoría clínica importante, evidenciada en consultas. Conclusiones. El perampanel puede suponer una alternativa eficaz para el tratamiento de las mioclonías en pacientes con mioclono posthipóxico crónico.
Assuntos
Parada Cardíaca/complicações , Hipóxia Encefálica/complicações , Mioclonia/tratamento farmacológico , Nitrilas/uso terapêutico , Piridonas/uso terapêutico , Anticonvulsivantes/uso terapêutico , Carcinoma Papilar/cirurgia , Clonazepam/administração & dosagem , Clonazepam/uso terapêutico , Quimioterapia Combinada , Eletroencefalografia , Humanos , Levetiracetam/administração & dosagem , Levetiracetam/uso terapêutico , Masculino , Pessoa de Meia-Idade , Mioclonia/etiologia , Mioclonia/fisiopatologia , Nitrilas/administração & dosagem , Complicações Pós-Operatórias , Piridonas/administração & dosagem , Convulsões/etiologia , Convulsões/fisiopatologia , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia , Ácido Valproico/administração & dosagem , Ácido Valproico/uso terapêuticoRESUMO
The purpose of this review is to provide a comprehensive update and highlight the distinct electroclinical features and discuss recent advances in the etiology, pathophysiology, and management strategies of epilepsy with eyelid myoclonia. Recent studies indicate that variations of certain genes including CHD2 (chromodomain helicase DNA-binding protein 2), KCNB1, KIAA2022, and NAA10 may occur in these patients. It has been postulated that the occipital cortex may play a role in the pathophysiology. Recent studies of functional imaging and connectivity of neuronal electrical activity have provided additional evidence to support this hypothesis. The frontal cortex has additionally been implicated, and it has been suggested that the epileptic cortex may extend beyond the occipital cortex to involve the posterior temporal cortex. We update the management strategies and describe tools that may predict seizure persistence. Epilepsy with eyelid myoclonias, or Jeavons syndrome, is an idiopathic generalized epilepsy characterized by the triad of eyelid myoclonia with or without absence seizures, eyelid closure-elicited electroencephalographic (EEG) paroxysms (epileptiform discharges and/or seizures), and photosensitivity. This condition may account for up to 13% of generalized epilepsies. However, it is frequently under-reported and under-recognized. Many of the patients develop medically refractory epilepsy, and seizures tend to persist throughout life.
Assuntos
Epilepsia Generalizada/fisiopatologia , Doenças Palpebrais/fisiopatologia , Mioclonia/fisiopatologia , Criança , HumanosRESUMO
Propriospinal myoclonus (PSM) consists of paroxysmal and sudden jerks involving axial flexion trunk and hip muscles, conditioning sudden myoclonias of the trunk and arms/limbs, both spontaneous and triggered by sensory stimulations, emerging in relaxed wakefulness typically during the transition between wake and sleep. Generally, PSM originates from a thoracic myelomere and spreads caudally and rostrally, provoking flexion and/or extension movements, leading to jumps or trunk jerks. They appear triggered by the lying-down position and disappear when the subject stands up. The main consequences are the difficulties in sleep start and the reappearance during the period of wakefulness after sleep onset.
Assuntos
Mioclonia/fisiopatologia , HumanosAssuntos
Ataxia/fisiopatologia , Lipomatose/diagnóstico por imagem , Síndrome MERRF/fisiopatologia , Mioclonia/fisiopatologia , Idoso , DNA Mitocondrial/genética , Testes Genéticos , Humanos , Síndrome MERRF/diagnóstico , Síndrome MERRF/genética , Imageamento por Ressonância Magnética , Masculino , PescoçoAssuntos
Doenças Autoimunes do Sistema Nervoso/tratamento farmacológico , Benserazida/farmacologia , Dopaminérgicos/farmacologia , Encefalomielite/tratamento farmacológico , Levodopa/farmacologia , Rigidez Muscular/tratamento farmacológico , Mioclonia/tratamento farmacológico , Receptores de Glicina/imunologia , Adulto , Autoanticorpos , Doenças Autoimunes do Sistema Nervoso/imunologia , Doenças Autoimunes do Sistema Nervoso/fisiopatologia , Benserazida/administração & dosagem , Dopaminérgicos/administração & dosagem , Combinação de Medicamentos , Encefalomielite/imunologia , Encefalomielite/fisiopatologia , Humanos , Levodopa/administração & dosagem , Masculino , Rigidez Muscular/imunologia , Rigidez Muscular/fisiopatologia , Mioclonia/imunologia , Mioclonia/fisiopatologiaAssuntos
Músculos Abdominais/diagnóstico por imagem , Isquemia Encefálica/diagnóstico por imagem , Córtex Cerebral/diagnóstico por imagem , Epilepsia Parcial Contínua/diagnóstico por imagem , Gravação em Vídeo/métodos , Músculos Abdominais/fisiopatologia , Idoso , Isquemia Encefálica/complicações , Isquemia Encefálica/fisiopatologia , Epilepsia Parcial Contínua/etiologia , Epilepsia Parcial Contínua/fisiopatologia , Humanos , Masculino , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , Mioclonia/fisiopatologiaAssuntos
Acamprosato/efeitos adversos , Dissuasores de Álcool/efeitos adversos , Alcoolismo/tratamento farmacológico , Mioclonia/diagnóstico , Acamprosato/administração & dosagem , Adulto , Dissuasores de Álcool/administração & dosagem , Diagnóstico Diferencial , Eletroencefalografia , Humanos , Masculino , Mioclonia/induzido quimicamente , Mioclonia/fisiopatologiaRESUMO
OBJECTIVES: The objective of this study is to describe the mechanism of damage to subcortical structures in chronic kidney disease (CKD) and to describe the range of movement disorders associated with CKD. MATERIALS AND METHODS: We have reviewed the Medline literature up to January of 2020 using key words movement disorders and chronic kidney disease. The reviewed articles were studied for mechanisms of subcortical damage in CKD as well as type of the reported movements, their frequency and updated treatment. RESULTS: The search revealed 183 articles most of them dealing with restless legs syndrome. The damage to basal ganglia in CKD resulted from several mechanisms including accumulation of nitro tyrosine caused by reactive oxygen species and action of uremic toxins leading to endothelial damage and dysfunction of blood-brain barrier. Involuntary movements in CKD include restless legs syndrome (RLS), myoclonus, asterixis, dystonia, chorea, tremor, and Parkinsonism. CONCLUSIONS: Chronic kidney disease can cause several abnormal involuntary movements via damaging basal ganglia and subcortical structures. The most common movement disorders in CKD are RLS, myoclonus and asterixis. Restless legs syndrome and myoclonus when severe, need and respond to treatment. Movement disorders in CKD improve with improvement of kidney function.